Clinical Trials Directory

Trials / Completed

CompletedNCT05604443

Keratoconus Detection Using MS39 and Pentacam

Keratoconus Detection Using MS39 and Pentacam - a Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
173 (actual)
Sponsor
Johannes Kepler University of Linz · Academic / Other
Sex
All
Age
14 Years – 100 Years
Healthy volunteers

Summary

This retrospective study aims to investigate whether the MS39 and Pentacam are delivering comparable results in the diagnosis of keratoconus. In the future, these measurement devices could be interchangeable in usage.

Detailed description

Keratoconus is a degenerative pathology of the cornea, which tends to progress. It comes along with central and paracentral thinning of the cornea as well as with an apical protrusion of the cornea. Keratoconus leads to vision loss. This pathology is diagnosed by using CE certified OCT technology in order to map the topography of the cornea. This process constitutes a really important step in the line of management of the keratoconus. MS39 and Pentacam are used for detection. Retrospectively, data will be investigated, in order to see if these measurement devices deliver comparable results. In the future, these measurement devices could be interchangeable in usage.

Conditions

Interventions

TypeNameDescription
OTHERretrospective analyzeretrospective analyze of MS39 and Pentacam images

Timeline

Start date
2022-12-28
Primary completion
2023-04-01
Completion
2023-05-01
First posted
2022-11-03
Last updated
2023-10-13

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT05604443. Inclusion in this directory is not an endorsement.